This is the first comprehensive examination of transcript levels of ESPL1, PTTG1 and PTTG1IP in CML patients, and the observed overexpression confirms the role of ESPL1 as a surrogate marker of proliferation in CML [38,39]. This evidence concerns the gene ESPL1 and chronic myelogenous leukemia, BCR-ABL1 positive.